Hemoglobin glycation index (HGI), which is the difference between the observed value of HbA1 and the predicted HbA1c based on plasma glucose levels, represents a measure of the degree of non-enzymatic glycation of hemoglobin and it has been found to be positively associated with diabetic complications. Herein we investigated whether HGI is associated with hepatic steatosis and related biomarkers in subjects without diabetes.
Fiorentino, T.v., Marini, M.a., Succurro, E., Andreozzi, F., Sciacqua, A., Hribal, M.l., et al. (2017). Association between hemoglobin glycation index and hepatic steatosis in non-diabetic individuals. DIABETES RESEARCH AND CLINICAL PRACTICE, 134, 53-61 [10.1016/j.diabres.2017.09.017].
Association between hemoglobin glycation index and hepatic steatosis in non-diabetic individuals
Marini M. A.;Andreozzi F.;Hribal M. L.;Sesti G.
2017-01-01
Abstract
Hemoglobin glycation index (HGI), which is the difference between the observed value of HbA1 and the predicted HbA1c based on plasma glucose levels, represents a measure of the degree of non-enzymatic glycation of hemoglobin and it has been found to be positively associated with diabetic complications. Herein we investigated whether HGI is associated with hepatic steatosis and related biomarkers in subjects without diabetes.| File | Dimensione | Formato | |
|---|---|---|---|
|
1-s2.0-S0168822717308859-main.pdf
accesso aperto
Licenza:
Non specificato
Dimensione
578.79 kB
Formato
Adobe PDF
|
578.79 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
